Press "Enter" to skip to content

New patent for Kala Pharms drug EYSUVIS

2
Copyright © DrugPatentWatch. Originally published at New patent for Kala Pharms drug EYSUVIS

Annual Drug Patent Expirations for EYSUVIS
Annual Drug Patent Expirations for EYSUVIS

Eysuvis is a drug marketed by Kala Pharms Inc and is included in one NDA.

The generic ingredient in EYSUVIS is loteprednol etabonate. Additional details are available on the loteprednol etabonate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Kala Pharms drug EYSUVIS
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions